Rockwell Medical, Inc.
RMTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $15,927 | $16,071 | $18,914 | $24,665 |
| % Growth | -0.9% | -15% | -23.3% | – |
| Cost of Goods Sold | $13,655 | $13,568 | $15,872 | $21,034 |
| Gross Profit | $2,272 | $2,503 | $3,042 | $3,631 |
| % Margin | 14.3% | 15.6% | 16.1% | 14.7% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $3,325 | $3,280 | $3,691 | $3,306 |
| SG&A Expenses | $3,856 | $3,852 | $4,402 | $4,149 |
| Sales & Mktg Exp. | $531 | $572 | $711 | $843 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,856 | $3,852 | $4,402 | $4,150 |
| Operating Income | -$1,584 | -$1,349 | -$1,360 | -$519 |
| % Margin | -9.9% | -8.4% | -7.2% | -2.1% |
| Other Income/Exp. Net | -$169 | -$143 | -$155 | -$237 |
| Pre-Tax Income | -$1,753 | -$1,492 | -$1,515 | -$756 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,753 | -$1,492 | -$1,515 | -$756 |
| % Margin | -11% | -9.3% | -8% | -3.1% |
| EPS | -0.05 | -0.044 | -0.044 | -0.023 |
| % Growth | -14.9% | 2% | -93% | – |
| EPS Diluted | -0.05 | -0.044 | -0.044 | -0.023 |
| Weighted Avg Shares Out | 36,025 | 34,311 | 34,108 | 32,878 |
| Weighted Avg Shares Out Dil | 36,025 | 34,311 | 34,108 | 32,878 |
| Supplemental Information | – | – | – | – |
| Interest Income | $55 | $69 | $66 | $29 |
| Interest Expense | $285 | $276 | $277 | $289 |
| Depreciation & Amortization | $61 | $563 | $539 | $543 |
| EBITDA | -$1,407 | -$653 | -$699 | $76 |
| % Margin | -8.8% | -4.1% | -3.7% | 0.3% |